Results 171 to 180 of about 5,145,453 (383)

BCS1L‐Associated Disease: 5′‐UTR Variant Shifts the Phenotype Towards Axonal Neuropathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the consequences of a pathogenic missense variant (c.838C>T; p.L280F) and a 5′‐UTR regulatory variant (c.‐122G>T) in BCS1L on disease pathogenesis and to understand how regulatory variants influence disease severity and clinical presentation.
Rotem Orbach   +11 more
wiley   +1 more source

Systemic Haiku

open access: yesMurmurations, 2017
Various Systemic Practitioners
doaj   +1 more source

Multi-, trans- and inter-disciplinarity, essential conditions for the sustainable development of human habitat [PDF]

open access: yesUrbanism. Arhitectura. Constructii, 2013
While the hierarchy of inter-, trans- and multi-disciplinarity is not commonly agreed upon, the vast majority of authors emphasize the utility of integrating to more or lesser extent different disciplines in research.
Alexandru-Ionuţ Petrişor
doaj  

Symmetry of system and system of symmetry

open access: yesComputers & Mathematics with Applications, 1986
AbstractRelation “symmetry-system” is investigated from the point of view of the author's version of general systems theory (GST(U)). The symmetry of system is explicated in three ways: (i) in the form of the theory of groups of nonevolutionary and evolutionary system transformations and their invariants, (ii) in the form of a proof of symmetry of the ...
openaire   +2 more sources

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad   +8 more
wiley   +1 more source

LP-012 Patients with systemic lupus erythematosus and hyperproduction of antibodies to anti-U1RNP

open access: yesLupus Science and Medicine, 2023
Oxana Desinova   +6 more
doaj   +1 more source

Global epidemiology of systemic lupus erythematosus

open access: yesNature Reviews Rheumatology, 2021
M. Barber   +9 more
semanticscholar   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy